Literature DB >> 4851104

Comparison among four vehicles and four routes for administering delta9-tetrahydrocannabinol.

R D Sofia, R K Kubena, H Barry.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4851104     DOI: 10.1002/jps.2600630630

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  7 in total

Review 1.  Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.

Authors:  Evan C Rosenberg; Pabitra H Patra; Benjamin J Whalley
Journal:  Epilepsy Behav       Date:  2017-02-09       Impact factor: 2.937

2.  Drug discrimination procedures: differential characteristics of the drug A vs drug B and the drug A vs drug B vs no drug cases.

Authors:  M D Swedberg; T U Järbe
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Drug discrimination procedures: roles of relative stimulus control in two-drug cases.

Authors:  M D Swedberg; T U Järbe
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 4.  Intraperitoneal Route of Drug Administration: Should it Be Used in Experimental Animal Studies?

Authors:  Abdullah Al Shoyaib; Sabrina Rahman Archie; Vardan T Karamyan
Journal:  Pharm Res       Date:  2019-12-23       Impact factor: 4.200

5.  Behavioral and biochemical effects of chronic delta 9-tetrahydrocannabinol in rats.

Authors:  K A Miczek; B N Dixit
Journal:  Psychopharmacology (Berl)       Date:  1980-02       Impact factor: 4.530

Review 6.  Cannabinoids and Epilepsy.

Authors:  Evan C Rosenberg; Richard W Tsien; Benjamin J Whalley; Orrin Devinsky
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

7.  Cocaine cue in pigeons: time course studies and generalization to structurally related compounds (norcocaine, WIN 35,428 and 35,065-2) and (+)-amphetamine.

Authors:  T U Järbe
Journal:  Br J Pharmacol       Date:  1981-08       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.